Literature DB >> 31899282

Human pseudorabies virus infection: A new threat in China.

Jiajun Ou1, Siqi Cai2, Feiyan Zheng1, Gang Lu3, Guihong Zhang4.   

Abstract

Entities:  

Keywords:  China; Human; Pseudorabies virus

Year:  2019        PMID： 31899282     DOI： 10.1016/j.jinf.2019.12.018

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  6 in total

1.  The Activity of Plant-Derived Ren's Oligopeptides-1 against the Pseudorabies Virus.

Authors:  Danmei Xiao; Yu He; Qin Xiao; Luxia Cai; Haoqi Wang; Aikebaier Reheman; Ke Xiao
Journal:  Animals (Basel)       Date:  2022-05-25       Impact factor: 3.231

2.  Implication of the Identification of an Earlier Pseudorabies Virus (PRV) Strain HLJ-2013 to the Evolution of Chinese PRVs.

Authors:  Huimin Liu; Zhibin Shi; Chunguo Liu; Pengfei Wang; Ming Wang; Shida Wang; Zaisi Liu; Lili Wei; Zhenzhao Sun; Xijun He; Jingfei Wang
Journal:  Front Microbiol       Date:  2020-12-15       Impact factor: 5.640

3.  The Immunity Protection of Central Nervous System Induced by Pseudorabies Virus DelgI/gE/TK in Mice.

Authors:  Lei Xu; Jian-Feng Wei; Jun Zhao; Si-Yao Xu; Feng-Qin Lee; Min-Cai Nie; Zhi-Wen Xu; Yuan-Cheng Zhou; Ling Zhu
Journal:  Front Microbiol       Date:  2022-03-25       Impact factor: 5.640

Review 4.  Insights into the Anti-inflammatory and Antiviral Mechanisms of Resveratrol.

Authors:  Xiangxiu Chen; Xu Song; Xinghong Zhao; Yu Zhang; Yiming Wang; Renyong Jia; Yuanfeng Zou; Lixia Li; Zhongqiong Yin
Journal:  Mediators Inflamm       Date:  2022-08-12       Impact factor: 4.529

Review 5.  Virus Safety of Xenotransplantation.

Authors:  Joachim Denner
Journal:  Viruses       Date:  2022-08-30       Impact factor: 5.818

6.  Absent immune response to SARS-CoV-2 in a 3-month recurrence of coronavirus disease 2019 (COVID-19) case.

Authors:  Guosheng Gao; Zhe Zhu; Lingyan Fan; Shuyuan Ye; Zuoan Huang; Qiaoyun Shi; Yedan Sun; Qifa Song
Journal:  Infection       Date:  2020-07-28       Impact factor: 7.455
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.